Found: 5
Select item for more details and to access through your institution.
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 953, doi. 10.1007/s00262-011-1004-8
- By:
- Publication type:
- Article
Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4.
- Published in:
- Genome Medicine, 2019, v. 11, n. 1, p. 1, doi. 10.1186/s13073-019-0697-8
- By:
- Publication type:
- Article
Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines.
- Published in:
- ChemBioChem, 2021, v. 22, n. 7, p. 1215, doi. 10.1002/cbic.202000687
- By:
- Publication type:
- Article
IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 7, p. 913, doi. 10.1007/s00262-017-1995-x
- By:
- Publication type:
- Article
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma.
- Published in:
- Nature Medicine, 2015, v. 21, n. 1, p. 81, doi. 10.1038/nm.3773
- By:
- Publication type:
- Article